Polaryx Therapeutics, Inc. Common Stock (PLYX) is a publicly traded the market company. As of May 21, 2026, PLYX trades at $3.52 with a market cap of $130.67M and a P/E ratio of 0.00. PLYX moved +11.11% today. Year to date, PLYX is +0.00%; over the trailing twelve months it is flat. Its 52-week range spans $2.20 to $48.91. Analyst consensus is buy with an average price target of $10.00. Rallies surfaces PLYX's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Polaryx Therapeutics, Inc. Common Stock (PLYX) research on Rallies includes live charts, financials, analyst ratings, hedge fund holdings, politician trades, insider activity, news, AI research, and community context. PLYX moved +11.11% today. Analyst consensus is buy.
| Metric | Value |
|---|---|
| Price | $3.52 |
| Market Cap | $130.67M |
| P/E Ratio | 0.00 |
| EPS | $0.00 |
| Dividend Yield | 0.00% |
| 52-Week High | $48.91 |
| 52-Week Low | $2.20 |
| Volume | 168.85K |
| Avg Volume | 0 |
| Revenue (TTM) | $0 |
| Net Income | $0 |
| Gross Margin | 0.00% |
1 analysts cover PLYX: 0 strong buy, 1 buy, 0 hold, 0 sell, 0 strong sell. Consensus rating is buy. Average price target: $10.00.